Strides Arcolab’s wholly owned subsidiary Onco Therapies, has received US Food and Drug Administration (USFDA) final approval for Abbreviated New Drug Application (ANDA) for Vinorelbine Injection USP, 10 mg/mL packaged in 10 mg/1 mL and 50 mg / 5mL single-dose vials.
Vinorelbine is part of the Oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch. Vinorelbine is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cancer cell growth.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1531.05 |
Dr. Reddys Lab | 6428.05 |
Cipla | 1482.30 |
Zydus Lifesciences | 1093.45 |
Lupin | 1637.60 |
View more.. |